UnitedHealth Group (UNH)
(Delayed Data from NYSE)
$575.00 USD
-2.07 (-0.36%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $575.31 +0.31 (0.05%) 7:58 PM ET
2-Buy of 5 2
B Value D Growth D Momentum D VGM
Fundamental Charts
About Cash from Investing (TTM)
The company's trailing twelve month (TTM) Cash from Investing is the sum of the company's past 12 months cash position resulting from any gains or losses from investments in the financial markets, operating activities, and changes resulting from amounts spent on investments in capital assets such as plant and equipment. When evaluating the Cash from Investing value, it is important to consider each of the various activities which contribute to the overall change in cash position. A company can have a negative cash flow from investing and have a positive cash from Cash from operations or financing.
UNH 575.00 -2.07(-0.36%)
Will UNH be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for UNH based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for UNH
UnitedHealth at 19.09X P/E: Worth the Price or Time to Take Profits?
3 Top Large Cap Stocks for a Stable Approach: ETN, DECK, UNH
UNH: What are Zacks experts saying now?
Zacks Private Portfolio Services
Investors Heavily Search UnitedHealth Group Incorporated (UNH): Here is What You Need to Know
Should First Trust Dow 30 Equal Weight ETF (EDOW) Be on Your Investing Radar?
UnitedHealth Group (UNH) Stock Slides as Market Rises: Facts to Know Before You Trade
Other News for UNH
Dividend Champion, Contender, And Challenger Highlights: Week Of September 22
High insulin prices spur a federal lawsuit against three pharmacy benefit managers
FTC sues prescription drug middlemen, alleging they conspired over high insulin costs
UnitedHealth, Cigna, CVS PBMs targeted by FTC over inflated insulin prices
American Century Sustainable Equity Fund Q2 2024 Commentary